Informations
 -  Le projet EuroMyasthenia
+ Partenaires associés
+ Partenaires collaborant au réseau
+ Lettre d'information
+ Comment utiliser ce site ?
+ To submit [en]
Activités ...
+ Travail de recherche dans le Réseau
Agenda

Préférences

 Nombre de membres 259 membres


Utilisateurs en ligne

( personne )
Webmestre - Infos
Ecrire à Jacky Bismuth (Public Euromyasthenia Website)  Webmestre
Ajouter aux favoris  Favoris
Recommander ce site à un ami  Recommander
Version mobile   Version mobile

Le projet EuroMyasthenia - Vue d'ensemble : Activités [en]

Several activities will be developed according to the main objectives:

  • Health Information. Referral laboratories will be established and experts will provide professional assistance and information throughout the European Community. A leaflet will be prepared for patients about their disease. An officially endorsed Website and a forum will be provided. It will be open to all citizens but access to database will be restricted for professionals. An electronic newsletter will be sent to all members every two months.
  • European database. EuroMyasthenia will result in the creation of a European database that will collect data from a large part of Europe and thus permit epidemiological studies, taking into account genetic, immunological, histological, clinical, and hormonal aspects. Health indicators recommended by the ECHI-2 network and relevant to MG will be also included. At least 5000 patients from the European countries participating to this network will be included during the implementation of this project.
  • Epidemiological data collection. Epidemiological studies will be performed to monitor occurrence of the different forms of MG for individual countries and to identify new markers associated with disease pathogenic mechanisms. In turn, a list of recommended indicators will be established for the surveillance of Myasthenia Gravis in the member states and accession countries.
  • Standardization and Quality Assessment. European Guidelines for diagnosis and clinical management of MG will be prepared. A quality control system for laboratory diagnosis of the different forms of MG will be established. By educational and training visits in the expert centers, scientific and medical personnel will improve healthcare quality. In addition, the promotion of information between the different research groups will contribute to improve the knowledge of the immunologic and genetic pathological mechanisms of MG.



Date de création : 24/10/2006 - 5:09 PM
Dernière modification : 22/05/2007 - 10:46 AM
Catégorie : Le projet EuroMyasthenia
Page lue 2027 fois


Prévisualiser la page Prévisualiser la page     Imprimer la page Imprimer la page

react.gifRéactions à cet article


Personne n'a encore laissé de commentaire.
Soyez donc le premier !


logo_idf.gif
Image 1.png
Lettre d'information
Pour avoir des nouvelles du projet EuroMyasthenia, inscrivez-vous à notre Newsletter.
S'abonner
Se désabonner
1331 Abonnés
Recherche




Zone d'accès restreint

Cette zone est dédiée aux cliniciens, chercheurs et associations de patients qui sont partenaires dans le réseau 'EuroMyasthenia' (associés et collaboratifs).

Entrez

(vous devez avoir un login et un mot de passe spécial)

Visites

   visiteurs

   visiteur en ligne

^ Haut ^

  Site créé avec GuppY v4.5.19 © 2004-2005 - Licence Libre CeCILL
Visitez VracInfo